Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy (RELY)
Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy - A Randomized Controlled Trial
Sponsor: Heidelberg University
This NA trial investigates Colorectal Cancer and Hepatic Metastases and is currently ongoing. Heidelberg University leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Jan 2021 [monthly]
Enrolling By Invitation NA
▶ Show 3 earlier versions
-
Nov 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
Status: Unknown Status → Enrolling By Invitation
-
Feb 2017 — Nov 2017 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heidelberg University
For direct contact, visit the study record on ClinicalTrials.gov .